Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NIH plans cause a stir abroad

In March, the NIH made a little-noticed announcement of plans that will affect the right of ownership to inventions made under funding agreements (grants, cooperative agreements, contracts, subgrants, and subcontracts) with foreign entities. In Europe and elsewhere, the move is seen as a blow to international research cooperation.

The policy change was initiated "in response to concerns expressed by Congress," according to George Stone, chief of the Extramural Inventions and Technology Resources Branch,

Read the full 723 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers